Amyloid and lipids in the pathology of Alzheimer disease.
暂无分享,去创建一个
M. Emmerling | A. Roher | Y. Kuo | S. Gracon | K. Kokjohn
[1] Steven G. Clarke,et al. Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity* , 1999, The Journal of Biological Chemistry.
[2] P. Greengard,et al. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Gandy,et al. Involvement of Cell Surface Glycosyl-phosphatidylinositol-linked Aspartyl Proteases in α-Secretase-type Cleavage and Ectodomain Solubilization of Human Alzheimer β-Amyloid Precursor Protein in Yeast* , 1998, The Journal of Biological Chemistry.
[4] M. Emmerling,et al. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. , 1998, Biochemical and biophysical research communications.
[5] D. Peterson,et al. Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[6] T. Mizuno,et al. Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells. , 1998, Biochimica et biophysica acta.
[7] K. Welsh-Bohmer,et al. APOE genotype predicts when — not whether — one is predisposed to develop Alzheimer disease , 1998, Nature Genetics.
[8] B. Greenberg,et al. Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol* , 1998, The Journal of Biological Chemistry.
[9] Y. Luo,et al. Amyloid Precursor Protein Processing in Sterol Regulatory Element-binding Protein Site 2 Protease-deficient Chinese Hamster Ovary Cells* , 1998, The Journal of Biological Chemistry.
[10] H. Soininen,et al. Longitudinal SPECT study in Alzheimer’s disease: relation to apolipoprotein E polymorphism , 1998, Journal of neurology, neurosurgery, and psychiatry.
[11] K Namekata,et al. Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease. , 1998, The American journal of pathology.
[12] B. Strooper,et al. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Paganetti,et al. Lack of β‐amyloid production in M19 cells deficient in site 2 processing of the sterol regulatory element binding proteins , 1998, FEBS letters.
[14] A. von Eckardstein,et al. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. , 1998, The Journal of clinical investigation.
[15] J. Poirier,et al. β‐Amyloid Peptides Increase the Binding and Internalization of Apolipoprotein E to Hippocampal Neurons , 1998, Journal of neurochemistry.
[16] B T Hyman,et al. Progression of Cerebral Amyloid Angiopathy: Accumulation of Amyloid-ß40 in Affected Vessels , 1998, Journal of neuropathology and experimental neurology.
[17] T. Kodama,et al. βAPP γ‐secretase and SREBP site 2 protease are two different enzymes , 1998 .
[18] S. DeKosky,et al. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene , 1998, Neuroscience Letters.
[19] Y. Ihara,et al. GM1 Ganglioside-Bound Amyloid β-Protein in Alzheimer’s Disease Brain , 1998, Neurobiology of Aging.
[20] J. Seelig,et al. Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. , 1997, Biochemistry.
[21] M. T. Hasan,et al. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. , 1997, Molecular cell.
[22] B. Permanne,et al. Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants. , 1997, Biochemical and biophysical research communications.
[23] E. Matsubara,et al. Isoform‐Specific Effects of Apolipoproteins E2, E3, and E4 on Cerebral Capillary Sequestration and Blood‐Brain Barrier Transport of Circulating Alzheimer's Amyloid β , 1997, Journal of neurochemistry.
[24] S. Paul,et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.
[25] Xi Chen,et al. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease , 1997, Nature.
[26] L. Mucke,et al. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease , 1997, Nature.
[27] B. Hyman,et al. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease. , 1997, Archives of neurology.
[28] R. Duara,et al. No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample , 1997, Neuroscience Letters.
[29] L. Choo-Smith,et al. Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane Vesicles* , 1997, The Journal of Biological Chemistry.
[30] W. D. Ehmann,et al. Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease , 1997, Neurobiology of Aging.
[31] J. Hardy,et al. The presenilins and Alzheimer's disease. , 1997, Human molecular genetics.
[32] L. Fenart,et al. A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier , 1997, The Journal of cell biology.
[33] Daniel Steinberg,et al. Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.
[34] D. D'urso,et al. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[35] Z. Janka,et al. Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease , 1997, Neuroscience Letters.
[36] M. Mattson,et al. 4‐Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule‐associated protein tau , 1997, Neuroreport.
[37] H. Braak,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[38] L. Thal,et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease , 1997, Neurology.
[39] M. Sugawa,et al. Oxidized low density lipoprotein caused CNS neuron cell death , 1997, Brain Research.
[40] D. Wilson,et al. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. , 1997, The American journal of pathology.
[41] M. Shapiro,et al. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein , 1997, Nature.
[42] John Hardy,et al. Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.
[43] S. Birge. The role of estrogen in the treatment of Alzheimer's disease , 1997, Neurology.
[44] P. Greengard,et al. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Commenges,et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.
[46] P. Ianna,et al. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. , 1997, The Biochemical journal.
[47] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[48] A. Hofman,et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. , 1997, JAMA.
[49] T. Hashimoto,et al. Cloning and expression of cDNA for a newly identified isozyme of bovine liver 3-hydroxyacyl-CoA dehydrogenase and its import into mitochondria. , 1997, Biochimica et biophysica acta.
[50] T. Lehtimäki,et al. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains , 1997, Neurobiology of Aging.
[51] R. Motter,et al. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease , 1997 .
[52] S. Tsuji,et al. Aβ1–40 but not Aβ1–42 levels in cortex correlate with apolipoprotein E ϵ4 allele dosage in sporadic Alzheimer's disease , 1997, Brain Research.
[53] N. Craddock,et al. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population , 1997, Neuroscience Letters.
[54] T. Montine,et al. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. , 1997, The American journal of pathology.
[55] A Hofman,et al. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.
[56] A. Hofman,et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.
[57] D. Mann,et al. Preferential deposition of amyloid β protein (Aβ) in the form Aβ 40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele , 1997, Neuroscience Letters.
[58] A. Nordberg,et al. Application of PET in dementia disorders , 1996, Acta neurologica Scandinavica. Supplementum.
[59] R. Brasseur,et al. Fusogenic Properties of the C-terminal Domain of the Alzheimer β-Amyloid Peptide* , 1996, The Journal of Biological Chemistry.
[60] R. Mahley,et al. Human apolipoprotein E: the Alzheimer's disease connection , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[61] J. Bailey,et al. Isolation, mapping, and genomic structure of an X-linked gene for a subunit of human mitochondrial complex I. , 1996, Genomics.
[62] A. Koudinov,et al. Multiple inhibitory effects of Alzheimer's peptide Aβ1–40 on lipid biosynthesis in cultured human HepG2 cells , 1996, FEBS letters.
[63] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[64] F. LaFerla,et al. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. , 1996, The Journal of clinical investigation.
[65] A. Roher,et al. Specific Domains of β-Amyloid from Alzheimer Plaque Elicit Neuron Killing in Human Microglia , 1996, The Journal of Neuroscience.
[66] L. Mucke,et al. Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[67] Douglas Walker,et al. Inflammation and Alzheimer's disease pathogenesis , 1996, Neurobiology of Aging.
[68] C. Gottfries,et al. Membrane Components Separate Early-Onset Alzheimer's Disease From Senile Dementia of the Alzheimer Type , 1996, International Psychogeriatrics.
[69] F. Maxfield,et al. Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.
[70] J. Loike,et al. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils , 1996, Nature.
[71] X. Chen,et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.
[72] W. Goux,et al. Characterization of the Glycolipid Associated with Alzheimer Paired Helical Filaments , 1996, Journal of neurochemistry.
[73] X. Hua,et al. Sterol-Regulated Release of SREBP-2 from Cell Membranes Requires Two Sequential Cleavages, One Within a Transmembrane Segment , 1996, Cell.
[74] R. Beavis,et al. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins. , 1996, Biochemical and biophysical research communications.
[75] R N Kalaria,et al. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. , 1996, The American journal of pathology.
[76] D. Selkoe,et al. Antibodies to amyloid β protein (Aβ) crossreact with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) , 1996, Neurobiology of Aging.
[77] X. Hua,et al. Regulated Cleavage of Sterol Regulatory Element Binding Proteins Requires Sequences on Both Sides of the Endoplasmic Reticulum Membrane (*) , 1996, The Journal of Biological Chemistry.
[78] T. Berezov,et al. Alzheimer's peptides A beta 1-40 and A beta 1-28 inhibit the plasma cholesterol esterification rate. , 1996, Biochemistry and molecular biology international.
[79] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[80] M. Gearing,et al. Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease , 1996 .
[81] W. Klein,et al. Cholesterol Modulates -Secretase Cleavage of Amyloid Precursor Protein (*) , 1996, The Journal of Biological Chemistry.
[82] M. Ball,et al. Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*) , 1996, The Journal of Biological Chemistry.
[83] D. Borchelt,et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins , 1995, Neuron.
[84] K. Hamilton,et al. Immunoreactivity for apolipoprotein A-IV in tanycytes and astrocytes of rat brain , 1995, Neuroscience Letters.
[85] D. Holtzman,et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[86] B. Hyman,et al. Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy , 1995 .
[87] D. Sparks,et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.
[88] P. Moran,et al. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[89] W. Goux,et al. Analysis of the core components of Alzheimer paired helical filaments A gas chromatography/mass spectrometry characterization of fatty acids, carbohydrates and long‐chain bases , 1995, FEBS letters.
[90] E M Wijsman,et al. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.
[91] L. Higgins,et al. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[92] J. Joseph,et al. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging , 1995, Trends in Neurosciences.
[93] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[94] Y. Ihara,et al. Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. , 1994, The Journal of biological chemistry.
[95] P. Matsudaira,et al. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. , 1994, The Journal of biological chemistry.
[96] C. Gottfries,et al. Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) , 1994, Journal of neurochemistry.
[97] Stephen W. Scheff,et al. Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.
[98] A. Lacko,et al. Plasma lipids and cholesterol esterification in Alzheimer's disease , 1994, Mechanisms of Ageing and Development.
[99] M J Ball,et al. beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[100] M. Ball,et al. Morphological and Biochemical Analyses of Amyloid Plaque Core Proteins Purified from Alzheimer Disease Brain Tissue , 1993, Journal of neurochemistry.
[101] A D Roses,et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[102] L. Herbette,et al. X‐Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β‐Amyloid Peptide Interactions a , 1993, Annals of the New York Academy of Sciences.
[103] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[104] Carl W. Cotman,et al. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[105] S. Sisodia. Beta-amyloid precursor protein cleavage by a membrane-bound protease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[106] C. White,et al. Alzheimer disease paired helical filament core structures contain glycolipid. , 1991, Biochemical and biophysical research communications.
[107] D. Graham,et al. βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.
[108] Carl W. Cotman,et al. In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.
[109] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[110] K. Tanaka,et al. "Secretase," Alzheimer amyloid protein precursor secreting enzyme is not sequence-specific. , 1991, Biochemical and biophysical research communications.
[111] D. Sparks,et al. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease , 1990, Neurobiology of Aging.
[112] G. Lenzi,et al. Serum lipoprotein pattern variations in dementia and ischemic stroke , 1990, Acta neurologica Scandinavica.
[113] A. Wallin,et al. Decreased myelin lipids in Alzheimer's disease and vascular dementia , 1989, Acta neurologica Scandinavica.
[114] K. Horiuchi,et al. Structure and expression of mouse apolipoprotein E gene. , 1989, Journal of biochemistry.
[115] M. Paula-Barbosa,et al. ALZHEIMER'S DISEASE: PAIRED HELICAL FILAMENTS AND CYTOMEMBRANES , 1987, Neuropathology and applied neurobiology.
[116] T. Sunderland,et al. Prospective study of risk factors for Alzheimer's disease: results at 7.5 years. , 1999, The American journal of psychiatry.
[117] J. Morris,et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia , 1998, Nature Genetics.
[118] E. Feskens,et al. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. , 1997, American journal of epidemiology.
[119] W. Grant. Dietary Links to Alzheimer's Disease , 1997 .
[120] H. Wiśniewski,et al. Beta-protein immunoreactivity in the human brain after cardiac arrest. , 1996, Folia neuropathologica.
[121] T. Okumura,et al. Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. , 1996, The American journal of physiology.
[122] T. Scott,et al. Severe cardiovascular disease and Alzheimer's disease: Senile plaque formation in cortical areas , 1996, Clinical anatomy.
[123] C. Bieberich,et al. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.
[124] D. Selkoe,et al. Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.
[125] J. Miller,et al. Amino acid sequence of rabbit apolipoprotein E. , 1991, Journal of lipid research.
[126] C. Sing,et al. Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.